In the news
July 27, 2021
Each year, patient specimens arrive at Mayo Clinic Laboratories from all 50 states and from more than 80 countries. But sending samples for testing to Rochester, Minnesota, from outside of the United States can be difficult in some cases. To help overcome that, Mayo Clinic Laboratories' international strategy is focusing on extending highly specialized testing within key countries, so they don't have to export testing to the U.S.
“The world is changing, and some governments are limiting exportation of biological samples for testing,” says Mohamed Salama, M.D., Mayo Clinic Laboratories' chief medical officer. “We anticipate having an embedded presence in regions where we have longstanding relationships, with some personnel from the U.S. living in those areas, working alongside local personnel.”
A feature in Mayo Clinic Alumni magazine details how Mayo Clinic Laboratories is reaching out around the world through strategic partnerships such as the one the organization has established with American Hospital Dubai.
"Our philosophy is that the best approach to lab testing is to keep it as close to the patient as possible to facilitate immediacy of results,” says William Morice II, M.D., Ph.D. Mayo Clinic Laboratories' president. “Strategic partnerships such as these will help keep testing in regions as much as possible, with Mayo Clinic Laboratories in the U.S. as an additional resource when local capabilities and expertise aren’t sufficient."
Read the full Mayo Clinic Alumni story here.